Cargando…
Effect of Dexamethasone on Abiraterone Pharmacokinetics in Mice: Determined by LC/MS Analysis
Background: Abiraterone acetate is a cytochrome P450 17A1 (CYP17A1) inhibitor that is indicated for use in both castration-resistant and castration-sensitive prostate cancer patients. To manage the mineralocorticoid effects of CYP17A1 inhibition, a glucocorticoid such as dexamethasone is co-administ...
Autores principales: | Deb, Subrata, Ben-Eltriki, Mohamed, Adomat, Hans, Chin, Mei Y., Tomlinson Guns, Emma S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053955/ https://www.ncbi.nlm.nih.gov/pubmed/36976310 http://dx.doi.org/10.3390/medicines10030021 |
Ejemplares similares
-
Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions
por: Ben-Eltriki, Mohamed, et al.
Publicado: (2016) -
Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate Cancer
por: Ben-Eltriki, Mohamed, et al.
Publicado: (2021) -
Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue
por: Deb, Subrata, et al.
Publicado: (2021) -
Characterization of Precursor-Dependent Steroidogenesis in Human Prostate Cancer Models
por: Deb, Subrata, et al.
Publicado: (2018) -
20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors
por: Ben-Eltriki, Mohamed, et al.
Publicado: (2018)